Top Markets
Coin of the day
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc.

INTI
株式のランク #30838
Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida,... Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments for patients in the United States who suffer from various cancerous and non-cancerous cell proliferation conditions. A primary focus of their work involves advancing SUBA-Itraconazole, an oral variant of the drug itraconazole, for therapeutic applications in prostate and lung cancers. Furthermore, Inhibitor Therapeutics, Inc. has successfully completed a positive Phase 2b clinical trial for SUBA-Itraconazole in the management of basal cell carcinoma nevus syndrome. The organization was previously known as HedgePath Pharmaceuticals, Inc. until its name was officially changed in August 2019.
株価
$0.089
最終同期: 2026-08-17
時価総額
$15.36M
変化(1日)
50.59%
変化(1年)
111.85%
US
取引 Inhibitor Therapeutics, Inc. (INTI)

カテゴリー

Inhibitor Therapeutics, Inc.(INTI)の株価履歴
終値の最高値: $0.08 (2026-08-01)

終値の最安値: $13.64 (2003-09-01)
Inhibitor Therapeutics, Inc. の株価履歴(2003 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 36.71%
2025 -32.43%
2024 -25.17%
2023 28.96%
2022 -48.45%
2021 273.68%
2020 -20.00%
2019 -55.15%
2018 -60.33%
2017 -30.61%
2016 198.81%
2015 -0.18%
2014 51.76%
2013 -99.13%
2004 -21.95%
2003 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$527.89 35.40%
US
$996.61 50.70%
NL
$111.31 -36.83%
AU
$735.86 6.87%
CH
$257.75 13.01%
BE